Azithromycin 500 mg
Azithromycin 500 mg is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia
Bordetella Pertussis Colonisation Challenge Study
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
Clinical Trials (6)
Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia
Bordetella Pertussis Colonisation Challenge Study
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6